{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:47:59Z","timestamp":1777265279071,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the impact of chemotherapy on the risk of breast cancer-related lymphedema (BCRL), with a specific focus on effects of different regimens, treatment duration (number of cycles), and timing of chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, 201 patients with pathologically confirmed breast cancer who underwent surgical treatment at Guangzhou Red Cross Hospital between January 1, 2020, and December2023, 2023 were enrolled. Group differences in BCRL incidence were analyzed using the chi-square test. Univariate logistic regression was used to identify factors associated with BCRL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BCRL occurred in 31 patients (15.4%). Univariate analysis revealed that tumor stage, axillary lymph node dissection, sentinel lymph node biopsy, chemotherapy, and regional nodal irradiation were significantly associated with BCRL (all P&amp;lt; 0.05). Taxane-based regimens (odds ratio [OR] = 4.018, 95% confidence interval [CI]: 1.162\u201313.890), long-course chemotherapy (OR\u00a0=\u00a04.887, 95% CI: 1.396\u201317.116), and the combination of neoadjuvant and adjuvant chemotherapy (OR\u00a0=\u00a04.50, 95% CI: 1.14\u201317.762) were significantly associated BCRL (all P&amp;lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Chemotherapy was associated with BCRL. Specifically, this association was observed with taxane-based regimens, long-course chemotherapy, and the combination of neoadjuvant and adjuvant chemotherapy. These findings highlight potential lymphotoxicity of specific regimens and may inform vigilant monitoring for BCRL in patients receiving such therapies, which could facilitate early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1787021","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:27:45Z","timestamp":1777264065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of chemotherapy on breast cancer\u2212related lymphedema: a retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Liqin","family":"Wang","sequence":"first","affiliation":[{"name":"Health Management Center (Preventive Treatment) of Baiyun Hospital, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemin","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangzhou Red Cross Hospital","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangzhou Red Cross Hospital","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangzhou Red Cross Hospital","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cici","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangzhou Red Cross Hospital","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1742","article-title":"Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection","volume":"154","author":"Armer","year":"2019","journal-title":"JAMA Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-024-02960-5","article-title":"Database study of risk factors for breast cancer-related lymphedema: a statistical analysis of 2359 cases over 10 years","volume":"55","author":"Matsumoto","year":"2025","journal-title":"Surg Today"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2460272","article-title":"Research trends of neoadjuvant therapy for breast cancer: a bibliometric analysis","volume":"21","author":"Xie","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09982-0","article-title":"Development and validation of an intraoperative nomogram to predict breast cancer-related lymphedema based on the arm lymphatics distribution","volume":"28","author":"Yuan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jso.27906","article-title":"The association of taxanes with breast cancer-related lymphedema","volume":"131","author":"Altundag","year":"2025","journal-title":"J Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-07183-9","article-title":"Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study","volume":"204","author":"Jia","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/jan.15005","article-title":"Breast cancer-related lymphoedema: risk factors and prediction model","volume":"78","author":"Martinez-Jaimez","year":"2022","journal-title":"J Adv Nurs"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.04.002","article-title":"Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: \u201cSTROBE-RDS\u201d statement","volume":"68","author":"White","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"B10","article-title":"The diagnosis and treatment of peripheral lymphedema: 2023 consensus document of The International Society of Lymphology","volume":"56","year":"2023","journal-title":"Lymphology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.06.2381","article-title":"Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective","volume":"274","author":"Byun","year":"2021","journal-title":"Ann Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000000468","article-title":"Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema","volume":"28","author":"Zhu","year":"2017","journal-title":"Anticancer Drugs"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1026043","article-title":"Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis","volume":"12","author":"Kim","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","article-title":"Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort","volume":"151","author":"Swaroop","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00520-018-4388-6","article-title":"Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study","volume":"27","author":"Penn","year":"2019","journal-title":"Support Care Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.20407\/fmj.2024-023","article-title":"Effect of docetaxel administration on fluid dynamics in mice","volume":"11","author":"Mawaki","year":"2025","journal-title":"Fujita Med J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051409","article-title":"Lymph-venous anastomosis for breast cancer-related lymphoedema after docetaxel-based chemotherapy","volume":"11","author":"Fuse","year":"2022","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/prs.0000000000009866","article-title":"The vicious circle of stasis, inflammation, and fibrosis in lymphedema","volume":"151","author":"Brown","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jso.28017","article-title":"Taxanes and breast cancer-related lymphedema","volume":"131","author":"Najafali","year":"2025","journal-title":"J Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3137-x","article-title":"Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients","volume":"148","author":"Jung","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2016.11.009","article-title":"Validation of a breast cancer nomogram to predict lymphedema in a Chinese population","volume":"210","author":"Li","year":"2017","journal-title":"J Surg Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.1628","article-title":"Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema","volume":"8","author":"Montagna","year":"2022","journal-title":"JAMA Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.08.016","article-title":"Reliable prediction of postmastectomy lymphedema: the Risk Assessment Tool Evaluating Lymphedema","volume":"213","author":"Basta","year":"2017","journal-title":"Am J Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnss.2019.12.007","article-title":"A scoring system for predicting the risk of breast cancer-related lymphedema","volume":"7","author":"Li","year":"2020","journal-title":"Int J Nurs Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.079","article-title":"Breast cancer-related lymphedema after neoadjuvant chemotherapy","volume":"47","author":"Kim","year":"2015","journal-title":"Cancer Res Treat"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/gox.0000000000007251","article-title":"The association of hand dominance with the development of breast cancer-related lymphedema after mastectomy: a retrospective analysis","volume":"13","author":"Clegg","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12911-022-01937-z","article-title":"Prediction of lymphedema occurrence in patients with breast cancer using the optimized combination of ensemble learning algorithm and feature selection","volume":"22","author":"Yaghoobi Notash","year":"2022","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:27:46Z","timestamp":1777264066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1787021"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1787021","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"article-number":"1787021"}}